Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority Study of a New Therapeutic Strategy for Gout: Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration - FEFACRIGOU Trial

NCT05109936 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT05109936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05109936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority Study of a New Therapeutic Strategy for Gout: Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration - FEFACRIGOU Trial
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Recruiting
Start date
August 2, 2023
Completion date
January 1, 2027
Enrollment
128 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gout